LY4006895

LY4006895 · Eli Lilly and Company

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LY4006895, covering 2026-03-27 to 2026-03-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study of LY4006895 in Healthy Participants With Early Symptomatic Alzheimer's Disease (AD) [Phase 1]